NASDAQ:CPRX

Catalyst Pharmaceuticals Stock Forecast

etoro logo Buy CPRX
*Your capital is at risk
$22.56
-0.620 (-2.67%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of CPRX
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Red day on Monday for Catalyst Pharmaceuticals
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Oct 31, 2025 Gain 6.06%

The Catalyst Pharmaceuticals stock price fell by -2.67% on the last day (Monday, 17th Nov 2025) from $23.18 to $22.56. During the last trading day the stock fluctuated 3.62% from a day low at $22.40 to a day high of $23.22. The price has risen in 6 of the last 10 days and is up by 5.22% over the past 2 weeks. Volume has increased on the last day by 35 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $25.85 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.91% during the next 3 months and, with a 90% probability hold a price between $22.35 and $25.51 at the end of this 3-month period.

CPRX Signals & Forecast

The Catalyst Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $22.51 and $21.21. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, November 14, 2025, and so far it has fallen -2.67%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Catalyst Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $21.39 and $20.91. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Catalyst Pharmaceuticals finds support just below today's level at $21.39. If this is broken, then the next support from accumulated volume will be at $20.91 and $19.78.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.81 between high and low, or 3.62%. For the last week, the stock has had daily average volatility of 4.05%.

Our recommended stop-loss: $21.71 (-3.78%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CPRX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Catalyst Pharmaceuticals to open at $22.73, and during the day (based on 14 day Average True Range), to move between $22.17 and $22.95, which gives a possible trading interval of +/-$0.789 (+/-3.56%) up or down from last closing price. If Catalyst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $22.78 (0.98%) than the support at $21.39 (5.19%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Catalyst Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Catalyst Pharmaceuticals stock to perform well in the short-term.

Current score: 2.855 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $22.73 ( 0.737%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CPRX Performance

Trading levels for CPRX

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 23.54 4.33%
R2 23.23 2.96%
R1 23.04 2.11%
Price 22.56
S1 22.42 -0.637%
S2 22.22 -1.49%
S3 21.91 -2.86%

Accumulated Volume Support & Resistance Levels

Level Price
R3 23.10 2.39%
R2 23.02 2.04%
R1 22.78 0.98%
Price 22.56
S1 21.39 -5.19%
S2 20.91 -7.31%
S3 19.78 -12.32%

FAQ

What is the symbol for Catalyst Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Catalyst Pharmaceuticals is CPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Catalyst Pharmaceuticals Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Catalyst Pharmaceuticals stock to perform well in the short-term.

How to buy Catalyst Pharmaceuticals Stock?
Catalyst Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Catalyst Pharmaceuticals Stock.

What's the current price of Catalyst Pharmaceuticals Stock?
As of the end of day on the Nov 17, 2025, the price of an Catalyst Pharmaceuticals (CPRX) share was $22.56.

What is the 52-week high and low for Catalyst Pharmaceuticals Stock?
The 52-week high for Catalyst Pharmaceuticals Stock is $26.51 and the 52-week low is $19.05.

What is the market capitalization of Catalyst Pharmaceuticals Stock?
As of the Nov 17, 2025, the market capitalization of Catalyst Pharmaceuticals is 2.773B.

When is the next earnings date for Catalyst Pharmaceuticals?
The upcoming earnings date for Catalyst Pharmaceuticals is Feb 25, 2026.
Click to get the best stock tips daily for free!
ABOUT CATALYST PHARMACEUTICALS
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE